1 Introduction
1.1 What Is This Report About?
1.2 Cardiac Rhythm Management Devices Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Cardiac Rhythm Management Devices Market, Canada
2.1 Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2024-2036
2.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), by Segment, 2024-2036
2.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), by Segment, 2024-2036
2.1.3 Pacemakers Market, Canada, Revenue ($m), by Segment, 2024-2036
2.2 Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2024-2036
2.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), by Segment, 2024-2036
2.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), by Segment, 2024-2036
2.2.3 Pacemakers Market, Canada, Volume (Units), by Segment, 2024-2036
2.3 Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2024-2036
2.4 Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), 2025
3 Cardiac Rhythm Management Devices Market Pipeline Products
3.1 Cardiac Rhythm Management Devices Market Pipeline Products
3.2 Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
3.3 Cardiac Rhythm Management Devices - Pipeline Products by Segment
3.4 Cardiac Rhythm Management Devices - Pipeline Products by Territory
3.5 Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
3.6 Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in Canada, Cardiac Rhythm Management Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Biotronik SE & Co KG
4.3.1 Company Overview
4.4 Boston Scientific Corp
4.4.1 Company Overview
4.5 MicroPort Scientific Corp
4.5.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
5.1.2 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
5.1.3 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI
5.1.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.1.5 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
5.1.6 Oct 03, 2025: Ventripoint Extends and Upsizes Non-Brokered Convertible Debenture Private Placement
5.2 Government and Public Interest
5.2.1 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
5.3 Other Significant Developments
5.3.1 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
5.3.2 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI
5.3.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.3.4 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit
5.4 Product News
5.4.1 Nov 11, 2025: AI/ML Innovations Announces Grant of U.S. Patent for ECG Signal-Processing Architecture
5.4.2 Nov 04, 2025: Researchers Uncover Genetic Basis of Heart Defects and Facial Differences in Syndrome
5.4.3 Nov 04, 2025: AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants for CardioYield Regulatory Submission in Jamaica
5.4.4 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
5.4.5 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
5.4.6 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
5.4.7 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit
5.4.8 Oct 06, 2025: QXMédical Announces Settlement With Teleflex, Clearing Path For U.S. Launch Of Boosting Catheter In 2026
5.4.9 Oct 01, 2025: Kardium Begins Commercialization Of Globe System In The USA
5.4.10 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
5.5 Strategy And Business Planning
5.5.1 Nov 04, 2025: AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants for CardioYield Regulatory Submission in Jamaica
5.5.2 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.5.3 Oct 01, 2025: Kardium Begins Commercialization Of Globe System In The USA
5.5.4 Sep 30, 2025: Icentia Reduces Inventory Time by 66% with Odoo
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the analyst Consulting
6.3 Contact the Publisher
6.4 Disclaimer
List of Tables
Table 1: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 2: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 3: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 4: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 5: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2024-2036
Table 6: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2024-2036
Table 7: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2024-2036
Table 8: Pacemakers Market, Canada, Volume (Units), 2024-2036
Table 9: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2024-2036
Table 10: Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 11: Cardiac Rhythm Management Devices Market Pipeline Products
Table 12: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Table 13: Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development
Table 14: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Table 15: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Table 16: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Table 17: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
Table 18: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 4: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 5: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2024-2036
Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2024-2036
Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2024-2036
Figure 8: Pacemakers Market, Canada, Volume (Units), 2024-2036
Figure 9: Cardiac Rhythm Management Devices Market, Canada, Company Share (%), 2025
Figure 10: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Figure 11: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Figure 12: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Figure 13: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Figure 14: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
